2020, Number 277
Relation between COVID-19 and cardiovascular diseases
Full text
Language: Spanish
References: 25
Page: 1-6
PDF size: 270.55 Kb.
ABSTRACT
Introduction: SARS-CoV-2 severe acute respiratory syndrome, which is a new coronavirus identified as the cause of 2019 coronavirus disease (COVID-19), started in Wuhan, China in late 2019 and has spread throughout the world. Among the effects it produces are those produced at the cardiovascular system level, which are becoming increasingly relevant thanks to its impact on mortality. Objective: to describe the relationship between COVID-19 and cardiovascular diseases. Material and methods: a bibliographic review was carried out in the period from January to April 2020. The review covered high-impact Web of Science journals, national and international journals, mostly from studies conducted in China. The Pubmed, MEDLINE and Scielo databases were consulted using the terms “coronavirus”, “COVID-19”, “cardiovascular system”, “myocarditis”; for English and Spanish. 25 articles with adequate validity were selected. Development: myocardial damage is a frequent complication among the most severe patients with COVID-19, which seems related to the systemic inflammatory response, the effect of dysregulation of the angiotensin II converting enzyme, as well as of lung dysfunction itself and hypoxia. Cardiovascular diseases reported so far include: myocarditis, acute coronary syndrome, and congestive heart failure. Material and methods: a bibliographic review was carried out in the period from January to April 2020. The review covered high-impact Web of Science journals, national and international journals, mostly from studies conducted in China. The Pubmed, MEDLINE and Scielo databases were consulted using the terms “coronavirus”, “COVID-19”, “cardiovascular system”, “myocarditis”; for English and Spanish. 25 articles with adequate validity were selected. Development: myocardial damage is a frequent complication among the most severe patients with COVID-19, which seems related to the systemic inflammatory response, the effect of dysregulation of the angiotensin II converting enzyme, as well as of lung dysfunction itself and hypoxia. Cardiovascular diseases reported so far include: myocarditis, acute coronary syndrome, and congestive heart failure. Conclusions: COVID-19 has a great relationship with cardiovascular diseases, which corresponds to the pathophysiology of the disease and the body’s response to it.REFERENCES
Galanti M, Birger R, Ud-Dean M, Filip I, Morita H, Comito D, et al. Longitudinal active sampling for respiratory viral infections across age groups. Influenza Other Respir Viruses.Circ Heart Fail [Internet] 2019 [citado 22 abril 2020] ;13 (3): 226-32. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468062/
Garabelli PJ, Modrall JG, Penninger JM, Ferrario CM, Chappell MC. Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart. Exp Physiol [Internet] 2008 [citado 22 abril 2020]; 93 (5): 613-21. Disponible en:https://utsouthwestern.pure.elsevier.com/en/publications/distinct-roles-for-angiotensin-converting-enzyme-2-and-carboxypep.
Kassiri Z, Zhong J, Guo D, Basu R, Wang X, Liu PP, et al. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circ Heart Fail [Internet] 2009 [citado 22 abril 2020]; 2 (5): 446-55. Disponible en: https://www.researchgate.net/publication/26875374_Loss_of_Angiotensin-Converting_Enzyme_2_Accelerates_Maladaptive_Left_Ventricular_Remodeling_in_Response_to_Myocardial_Infarction.
Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China LifeSci [Internet] 2020 [citado 22 abril 2020]; 63 (3): 364-74. Disponible en: https://www.researchgate.net/publication/339176279_Clinical_and_biochemical_indexes_from_2019-nCoV_infected_patients_linked_to_viral_loads_and_lung_injury.
Munster, VJ, Koopmans, M, van Doremalen, N. Un nuevo coronavirus emergente en China: preguntas clave para la evaluación de impacto. N Engl J Med [Internet] 2020 [citado 22 abril 2020]; 382 (8): 692 – 94. Disponible en: https://temas.sld.cu/coronavirus/2020/01/29/un-nuevo-coronavirus-emergente-en-china-preguntas-clave-para-la-evaluacion-de-impacto/
Barnes, M, Heywood, AE, Mahimbo, A. Infarto agudo de miocardio e influenza: un metanálisis de estudios de casos y controles. Corazón [Internet] 2015 [citado 22 abril 2020]; 101: 1738-47. Disponible en: http://ava.net.ve/noticias/788/infarto-agudo-del-miocardio-posterior-a-influenza-confirmada-por-laboratorio
Wang D, Hu B, Hu C. Características clínicas de 138 pacientes hospitalizados con nueva neumonía infectada con coronavirus 2019 en Wuhan, China. JAMA [Internet] 2020 [citado 22 abril 2020]; 382 (7): 690–94. Disponible en: https://temas.sld.cu/coronavirus/2020/02/11/caracteristicas-clinicas-de-138-pacientes-hospitalizados-con-infeccion-por-2019-ncov-en-wuhan-china/
Chen, N, Zhou, M, Dong, X. Características epidemiológicas y clínicas de 99 casos de nueva neumonía por coronavirus 2019 en Wuhan, China: un estudio descriptivo. Lancet [Internet] 2020 [citado 22 abril 2020]; 395 (10223): 507 - 13. Disponible en: https://www.inemec.edu.mx/blog/caracteristicas-epidemiologicas-y-clinicas-de-99-casos-de-neumonia-por-el-nuevo-coronavirus-2019-en-wuhan-china-un-estudio-descriptivo
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Lond Engl [Internet] 2020 [citado 22 abril 2020]; 315 (239): 507 – 13. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/downloads/Huang-2019-nCoV-clinical-features-Lancet-1-24-2020.pdf